2018 Annual Sessions

OS51 - ORAL SESSION 51 - I'm at Risk! Outcomes and Novel Risk Stratification in Pulmonary Hypertension

Apr 14, 2018 12:15pm ‐ Apr 14, 2018 1:45pm


Description

(497)  The United States Pulmonary Hypertension Scientific Registry (USPHSR): Objectives and Preliminary Data
Harrison Farber, MD

(498)  Non-invasive Right Ventricle-pulmonary Artery Coupling Predicts Events in Pulmonary Arterial Hypertension and in Left Heart Disease
Marco Vicenzi, MD

(499)  Echocardiography Predicts the Outcome in Pulmonary Arterial Hypertension Patients Treated With Parenteral Prostanoids
Roberto Badagliacca, MD, PhD

(500)  Stroke Volume Response to Exercise is Dependent on Disease Severity in Pulmonary Arterial Hypertension
Christoffer Göransson, MD

(501)  Application of Bayesian Model to Predict Outcomes in Pulmonary Arterial Hypertension
Manreet Kanwar, MD

(502)  Ralinepag, an Oral, Selective, Prostacyclin (IP) Receptor Agonist Consistently Improved Mortality Risk Scores Derived From PAH Registries Across Three Regions: Phase 2 Study Analysis
Raymond Benza, MD

Speaker(s):

You must be logged in and own this session in order to post comments.